N/A
N=31
MedActive: A Smartphone Intervention to Improve Adherence to Antipsychotic Medications
Schizophrenia
Bottom Line
View on ClinicalTrials.gov: NCT01953237 ↗Enrolled (actual)
31
Serious AEs
0.0%
Results posted
Dec 2016
Primary outcome: Primary: Adherence to Antipsychotic Medications — 92.6; 93.4 percentage of days adherent — p=0.5580
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- MedActive (Behavioral); Smartphone (Device)
- Age
- Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Maryland, Baltimore
- Primary completion
- Sep 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Adherence to Antipsychotic Medications |
92.6; 93.4 | 0.5580 |
Summary
We propose to develop and pilot test the effect of a mobile smartphone intervention, MedActive, on improving antipsychotic adherence among individuals with schizophrenia.
Eligibility Criteria
Inclusion Criteria
- Decisional capacity to provide informed consent
- Chart diagnosis of schizophrenia or schizoaffective disorder
- Currently prescribed at least one oral antipsychotic medication
- Self administers at least one oral antipsychotic medication
- 18-64 years of age
- English Speaking
- Be able to read English
Exclusion Criteria
- Has visual, hearing, voice, or motor impairment that would prevent completion of study procedures or use of mobile phone
Data sourced from ClinicalTrials.gov (NCT01953237). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.